KM023 / Kainos Medicine, Jiangsu Aidea Pharma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KM023 / Kainos Medicine
ChiCTR1900028166: Bioequivalence Study of Combination-ACC007 Tablets in Human

Completed
N/A
48
 
Tablet; Specification: Each tablet contains 150 mg of ACC007, 300 mg of lamivudine and 300 mg of tenofovir fumarate; it is orally administered on an empty stomach, 1 tablet per cycle, 2 cycles in total. ;Tablet; Specification: ACC007 2 tablets + lamivudine 1 tablet + tenofovir fumarate 1 tablet; oral administration on an empty stomach, 2 tablets per cycle, 2 cycles in total.
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School; Jiangsu Aidea Pharmaceutical Co., Ltd., Self-financing
HIV/ADIS
 
 

Download Options